Delivery Order SPE2DR25D3020-SPE2DR26F9R2B
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,860.27 to AmerisourceBergen Drug Corp for Xyosted 75 mg/0.5 mL auto-injector supplies. The contract, issued on December 18, 2025, with an ultimate completion date of December 19, 2025, represents a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,894.19 to AmerisourceBergen Drug Corp on January 6, 2026, for the supply of Xyosted 50 mg/0.5 ml auto-injector vials. This is a firm fixed-price, competitively awarded contract with no set-aside designation, with performance completed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order is expected to be fulfilled by January 7, 2026. AmerisourceBergen Drug Corp operates as the subsidiary of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Xyosted 75 mg/0.5 mL auto-injector supplies, valued at $1,308.97, with a firm fixed price structure. The contract, which was competitively awarded without set-aside designation, is scheduled for completion by November 18, 2025. The product will be performed and delivered from AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $1,577.70 to AmerisourceBergen Drug Corp for the supply of Xyosted 75 mg/0.5 mL auto-injector units. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of January 13, 2026, and was awarded on January 12, 2026. This award is a non-set-aside contract, competed on a full and open basis. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp...
- The Defense Logistics Agency awarded a delivery order valued at $6,233.99 to AmerisourceBergen Drug Corp for Xyosted 100 mg/0.5 ml auto-injector supplies, with a completion date of December 30, 2025. This is a firm fixed price, non-set-aside contract issued as a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to the company's facility in Conshohocken, Pennsylvania, where AmerisourceBergen serves as a major...
- The Defense Logistics Agency awarded a delivery order valued at $1,152.52 to AmerisourceBergen Drug Corp for Xyosted 100 mg/0.5 ml auto-injector supplies, with an ultimate completion date of April 25, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement supporting federal medical supply needs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for military and...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,205.98 to AmerisourceBergen Drug Corp for Xyosted 50 mg/0.5 mL auto-injector supplies. The contract is a firm fixed-price delivery order with an ultimate completion date of December 12, 2025, and was awarded on December 11, 2025, with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location....
- The Defense Logistics Agency awarded a delivery order valued at $1,293.84 to AmerisourceBergen Drug Corp for Xyosted 100 mg/0.5 ml auto-injector units. The contract is a firm fixed-price delivery order with an ultimate completion date of August 6, 2025, and represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location in the same municipality....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Xyosted 100 mg/0.5 mL auto-injector supplies, valued at $1,063.62 with a firm fixed price structure. The award was issued on December 16, 2025, with an ultimate completion date of December 17, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This non-set-aside contract represents a competitively awarded delivery order under the company's larger...
- The Defense Logistics Agency awarded a delivery order valued at $1,088.13 to AmerisourceBergen Drug Corp for Xyosted 50 mg/0.5 mL auto-injector supplies. The order was competitively awarded on December 11, 2025, with a completion date of December 12, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical...
- SPE2DR25D3020Indefinite Delivery Contract
- SPE2DR25D3020-SPE2DR26F9R2BDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,164.59 to AmerisourceBergen Drug Corp for Xyosted 75 mg/0.5 mL auto-injector prefilled syringes. The contract, which is a firm fixed-price delivery order without set-aside designation, was awarded on January 22, 2026, with an ultimate completion date of January 23, 2026. Performance will take place at the vendor's facility in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor and critical federal vendor specializing in supplying medications, vaccines, medical devices, and specialized healthcare commodities to military and veteran healthcare systems. The company operates through its parent organization Cencora, Inc., which holds a larger IDC with DLA valued at up to $999,999,999.00 through December 2031. Xyosted is a testosterone replacement therapy administered via auto-injector, representing the type of specialized pharmaceutical product that AmerisourceBergen routinely delivers across multiple therapeutic domains through its federal contract portfolio with the Defense Logistics Agency.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 1/21/26 |